|
English
|
正體中文
|
简体中文
|
總筆數 :0
|
|
造訪人次 :
51384722
線上人數 :
798
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"powles"的相關文件
顯示項目 1-3 / 3 (共1頁)
1
每頁顯示[10|25|50]項目
| 國立成功大學 |
2024-12 |
Enfortumab vedotin plus pembrolizumab (EV plus P) vs chemotherapy (Chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC): Pan-Asian subgroup analysis from EV-302/KEYNOTE-A39
|
Kikuchi;E;Heijden, van der;M, S.;Valderrama, Perez;B;Gupta;S;Bedke;J;Shin;S, J.;Li;J-R;Guo;J;Danchaivijitr;P;Kanesvaran;R;Park;S, H.;Su;W-P;Kandori;S;Bae;W, K.;Wong;A, S.;Lu;J;Yu;X;Shetty;A;Bavle;A, A. A.;Powles;T, B. |
| 國立成功大學 |
2024-09 |
Avelumab first-line (1L) maintenance in advanced urothelial carcinoma (aUC): Conditional survival and long-term safety in patients (pts) treated for ≥1 or ≥2 years in JAVELIN Bladder 100
|
Grivas;P;Park;S, H.;Voog;E;Su;W-P;Demey;W;Fong;P, C.;Garcia;J, A.;Jacob;N;Gerhold-Ay;A;Tyroller;K;Hoffman;J;Bellmunt;J;Powles;T, B. |
| 國立成功大學 |
2024-02-1 |
Enfortumab vedotin (EV) in combination with pembrolizumab (P) versus chemotherapy in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC): Subgroup analyses results from EV-302, a phase 3 global study
|
Heijden, Van Der;Simon, Michiel;Powles;Thomas;Gupta;Shilpa;Bedke;Jens;Kikuchi;Eiji;Wit, De;Ronald;Galsky;Matt, D.;Duran;Ignacio;Necchi;Andrea;Retz;Margitta;Yu;Evan, Y.;Hoffman-Censits;Jean, H.;Iyer;Gopa;Park;Hoon, Se;Su;Wen-Pin;Parmar;Hema;Guan;Xuesong;Gorla;Rao, Seema;Moreno, Homet;Blanca;Valderrama;Perez, Begona |
顯示項目 1-3 / 3 (共1頁)
1
每頁顯示[10|25|50]項目
|
